Key result
Childhood elevated non-HDL-C with normal LDL-C linked to ~94% higher adult ASCVD risk.
Cohort (n=21,126)
Yes
Hazard Ratio: 1.94 (95% CI 1.23–3.06)
Prospective cohort study finds childhood non-HDL-C better predicts adult cardiovascular events than LDL-C, indicating better assessment of risk.
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non–high-density lipoprotein cholesterol (non–HDL-C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non–HDL-C and LDL-C levels with adult ASCVD events and determined whether non–HDL-C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non–HDL-C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non–HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14–1.41] to 1.35 [95% CI, 1.13–1.60] per unit increase in the risk factor z score). Non–HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006–0.0102] and 0.0038 [95% CI, 0.0008–0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non–HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non–HDL-C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98–3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23–3.06]). CONCLUSIONS: Childhood non–HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non–HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non–HDL-C. These findings suggest that both non–HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non–HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) conducted a cohort in Atherosclerotic Cardiovascular Disease (n=21,126). Elevated childhood non-HDL cholesterol vs. Normal non-HDL-C and LDL-C levels was evaluated on Fatal/nonfatal ASCVD events for discordant elevated non-HDL-C and normal LDL-C vs concordant normal levels (HR 1.94, 95% CI 1.23-3.06). Childhood elevated non-HDL-C with normal LDL-C was associated with a higher risk of adult fatal or nonfatal ASCVD events compared to normal levels of both (HR 1.94; 95% CI 1.23-3.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: